SMARThealth offers a new approach to disease detection, management and treatment – strengthening primary care systems, building the capacity of health workers, and improving health outcomes for patients. SMARThealth (Systematic Medical Appraisal, Referral and Treatment for common health conditions) was developed by The George Institute for the management of chronic diseases. It leverages a low-cost, digital platform which can be used by health workers to significantly improve patient care, especially in contexts where health services are limited. Deployed on hand-held digital devices, SMARThealth uses evidence-based algorithms and guidelines to help community health workers assess chronic disease risks for people in their communities. People identified to be needing further care are then referred via the platform for clinician follow up. Extending SMARThealth The first iteration of SMARThealth was ‘HealthTracker’ used in Australia in 2009 to analyse the electronic health records o

The George Institute for Global Health is a global medical research institute that focuses on non-communicable diseases and injury.  With centres in four countries (Australia, China, India and the UK) and offices and staff in many others, we are monitoring the evolving COVID-19 situation.  As a global organisation experienced in operating across time zones with flexible working hours, we are well suited to working remotely and continuing to deliver on our mission to improve the health of millions of people worldwide.  A major focus for us is the safety and well-being of our staff across the globe and we are putting in place plans to ensure they are supported in their work and life, tailored for each setting we are in.    The George Institute will be monitoring external events and adjusting accordingly, with our staff, partners and research programs, front of mind. The importance of chronic disease co-morbidity in terms of the impact of COVID-19 infe

Globally efforts to improve women’s health largely focus on maternal health, overlooking women’s health needs beyond pregnancy and childbirth. The weight given to the maternal health outcome neglects the full range of women’s health. Diseases that affect women are substantially under-studied and under resourced. Gynaecological cancers and conditions like endometriosis, uterine fibroids, poly cystic syndrome, and cervical cancers might have been better understood if they also affected men. Since these are women-specific health issues that affect a woman’s quality of life across her lifespan, there has been little investment, particularly in low-and middle-income countries, to improve early diagnosis and treatment. For example, approximately 180 women globally with endometriosis remain undiagnosed and suffer from its symptoms like pain and infertility for almost seven years before getting diagnosed. Hence, more research and concerted action is needed to improve women’s health and to ensure tha

About us The George Institute for Global Health, together with its subsidiaries and associated companies worldwide (“The George Institute”, “we” and “our”) is committed to handling personal information (including health and other sensitive information) in accordance with applicable privacy laws, including the Australian Privacy Principles (“APPs”) set out in the Australian Privacy Act 1988 (Cth), and, where relevant, the EU General Data Protection Regulation ((EU 2016/679)(GDPR), or the retained version of the GDPR as it forms part of the law of England and Wales, Scotland and Northern Ireland by virtue of section 3 of the European Union (Withdrawal) Act 2018 as amended by Schedule 1 to the Data Protection, Privacy and Electronic Communications (Amendments, etc) (EU Exit) Regulations 2019 (SI 2019/419) (UK GDPR)  A reference to personal information includes “personal data” as defined in the GDPR and/or UK GDPR (as applicable).&nbs

1. Introduction The George Institute for Global Health (the Institute) strongly supports the view that: publicly funded research data are a public good which should be made available with as few restrictions as possible; greater data sharing could enhance public well‐being by maximising utilisation of gained knowledge, reducing redundant research and facilitating scientific innovation; and the approach to scientific data sharing must be responsible and must recognise legal, regulatory, ethical and commercial constraints. For this reason, the Institute formulated a policy and processes to allow appropriate and responsible sharing of the Institute’s research data for scientific research. 2. Scope This Data Sharing Policy (Policy) covers all studies conducted by the Institute globally and regardless of the source of funding. This policy applies to data sharing requests concerning prospective and completed Institute studies. In developing this